Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Anticancer Res. 1999 Nov-Dec;19(6A):4729-46.

    Oncogenes.

    Source

    Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard School of Dental Medicine, Boston 02114, USA. randy-todd@hms.harvard.edu

    Abstract

    Oncogenes are gain-of-function mutations of normal regulatory genes or proto-oncogenes. Originally discovered in retroviruses initiating a variety of animal and avian cancers, oncogenes are believed to be important contributors to human carcinogenesis. Proto-oncogenes are altered by point mutation, amplification or rearrangement. Structural alteration of proto-oncogenes leads to a quantitative or qualitative expression change of the corresponding protein product. Oncoproteins subvert signal transduction pathways at the cell surface, in the cytosol and/or in the nucleus. Together with other oncoproteins or in the absence of tumor suppressor gene products, oncogenes contribute to human cancer formation by supporting accelerated proliferation, de-regulating cell cycle control or blocking apoptosis.

    PMID:
    10697588
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      Recent activity

      • Oncogenes.
        Oncogenes.
        Anticancer Res. 1999 Nov-Dec ;19(6A):4729-46.
        PubMed

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk